4 reasons the global healthcare SCM market is growing

By Admin
Leading global technology research and advisory company Technavio anticipates the global healthcare supply chain management (SCM) market will post a com...

Leading global technology research and advisory company Technavio anticipates the global healthcare supply chain management (SCM) market will post a compound annual growth rate (CAGR) of 10 percent by 2020.

The analysts highlight the following four factors that are contributing to the growth of the global healthcare SCM market:

RELATED TOPIC: The impact of Taulia's new HIPAA-compliant supply chain finance solution

Need to reduce supply chain costs

Technavio’s latest report states that rising healthcare costs have compelled the healthcare industry to undergo structural and operational level changes to cut costs and boost overall efficiency. Also, inefficient supply chain management systems for implantable medical devices can lead to a loss of billions of dollars annually. Thus, with the help of SCM, hospitals can save money that may be deployed in hospital administration and capital expenditure.

Risk management in healthcare

SCM and risk management are needed to minimize supply-chain risks for healthcare providers. Pharmaceuticals companies are mitigating analytics supply-chain risks by process redesigning and analytics solutions.

RELATED TOPIC: Top 10 healthcare supply chain rankings

With the rapid expansion of supply chain systems and a decentralized base, healthcare providers need to manage their supply chain risks. Instabilities in the supply chain arise as healthcare providers are exposed to risks, such as unstable business cycles, unstable macroeconomic factors, high consumer demands, and natural disasters. Supply-chain risks hamper business performance by affecting business operations and financial stability.

Market consolidation in healthcare providers

The healthcare market is experiencing several M&A transactions by healthcare providers. In 2015, Pfizer, one of the prominent pharmaceutical companies, is set to buy Allergan for a market valuation of US$113 billion.

RELATED TOPIC: Is supply chain to blame for the recent Ecoli outbreak?

Teva Pharmaceuticals based in Hungary announced that it will buy generic drug unit of Allergan for US$40.5 billion. Drugstore operator CVS Health (CVS) is acquiring pharmacy services provider Omnicare (OCR) for US$12.7 billion.

Need to improve traceability in healthcare SCM systems

Healthcare providers are improving their inventory management system with the GS1 healthcare data standard for clear traceability of medical devices shipped across supply chains. The implementation of data standards increases patient’s safety by removing counterfeit products and minimizing the chances of human errors in the SCM systems of hospitals. It also increases the accuracy of ordered medical devices and invoicing, and prevents re-labelling of products at any point in the supply chain system.

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!



Featured Articles

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Johnson & Johnson takes collaborative approach to tackling the problem of carbon emissions in the global healthcare supply chain

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare

AstraZeneca & Celonis Map out Digital Transformation

Technology & AI